ML21095A219: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
(One intermediate revision by the same user not shown)
Line 17: Line 17:


=Text=
=Text=
{{#Wiki_filter:}}
{{#Wiki_filter:Chapter 10 - Experimental Facilities Table of Contents CHAPTER 10 EXPERIMENTAL FACILITIES TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 10-i Rev. 0 10.1
 
==SUMMARY==
DESCRIPTION............................................................................... 10.1-1
 
==10.2 REFERENCES==
................................................................................................... 10.2-1
 
Chapter 10 - Experimental Facilities List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 10-ii Rev. 0 None
 
Chapter 10 - Experimental Facilities List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 10-iii Rev. 0 None
 
Chapter 10 - Experimental Facilities Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 10-iv Rev. 0 None
 
Chapter 10 - Experimental Facilities Summary Description SHINE Medical Technologies 10.1-1 Rev. 0 CHAPTER 10 - EXPERIMENTAL FACILITIES 10.1
 
==SUMMARY==
DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012).
 
Chapter 10 - Experimental Facilities References SHINE Medical Technologies 10.2-1 Rev. 0
 
==10.2 REFERENCES==
USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012.}}

Latest revision as of 09:55, 29 November 2024

Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 10, Experimental Facilities
ML21095A219
Person / Time
Site: SHINE Medical Technologies
Issue date: 03/23/2021
From:
SHINE Medical Technologies
To:
Office of Nuclear Reactor Regulation
Shared Package
ML21095A241 List:
References
2021-SMT-0032
Download: ML21095A219 (6)


Text

Chapter 10 - Experimental Facilities Table of Contents CHAPTER 10 EXPERIMENTAL FACILITIES TABLE OF CONTENTS Section Title Page SHINE Medical Technologies 10-i Rev. 0 10.1

SUMMARY

DESCRIPTION............................................................................... 10.1-1

10.2 REFERENCES

................................................................................................... 10.2-1

Chapter 10 - Experimental Facilities List of Tables LIST OF TABLES Number Title SHINE Medical Technologies 10-ii Rev. 0 None

Chapter 10 - Experimental Facilities List of Figures LIST OF FIGURES Number Title SHINE Medical Technologies 10-iii Rev. 0 None

Chapter 10 - Experimental Facilities Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition SHINE Medical Technologies 10-iv Rev. 0 None

Chapter 10 - Experimental Facilities Summary Description SHINE Medical Technologies 10.1-1 Rev. 0 CHAPTER 10 - EXPERIMENTAL FACILITIES 10.1

SUMMARY

DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:

Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012).

Chapter 10 - Experimental Facilities References SHINE Medical Technologies 10.2-1 Rev. 0

10.2 REFERENCES

USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.

USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012.